Vanguard Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Vanguard Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,047,197	Closed	-$206M	–	4665
2022 Q1	$206M	Sell	11,047,197 -31,527	-0.3%	-$567K	﹤0.01%	1543
2021 Q4	$237M	Buy	11,078,724 +99,041	+0.9%	+$1.95M	0.01%	1495
2021 Q3	$203M	Buy	10,979,683 +3,147,462	+40%	+$63.4M	0.01%	1601
2021 Q2	$168M	Buy	7,832,221 +232,353	+3%	+$4.72M	﹤0.01%	1727
2021 Q1	$147M	Buy	+7,599,868	New	+$134M	﹤0.01%	1746

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Group's OCDX Position: Q2 2022 in Review

Vanguard Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 11,047,197 shares — an estimated $206M sold.

Vanguard Group first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $237M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Vanguard Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Vanguard Group sold 11,047,197 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $206M.
Vanguard Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Vanguard Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $237M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.